ANEB   $1.46  -10.43% Market Closed

Anebulo Pharmaceuticals Inc
Total Cash 3.09M
totalCashPerShare 0.119
EBITDA
Total Debt 0.00
quickRatio 11.874
currentRatio 13.462
Total Revenue
debtToEquity
Revenue/Share
ROA -0.65971
ROE -1.13803
grossProfits
freeCashflow -5.18M
operatingCashflow -8.09M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 45.40M
forwardPE -2.876923
floatShares 3.91M
sharesOutstanding 25.93M
sharesShort 11.56K
sharesShortPriorMonth 17.99K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.64%
heldPercentInstitutions 0.28%
Short Ratio help_outline 0.75%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.147
Price To Book help_outline 12.72
earningsQuarterlyGrowth
netIncomeToCommon -8.20M
trailingEps -0.33%
forwardEps -0.65%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.05 3Q 2024
institutionsCount 14
lastUpdated Nov. 7, 2024, 5:02 a.m.